Companies / Vaccinex, Inc.
Vaccinex, Inc.
VCNXCIK 1205922
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Friedberg Albert Director | Buy Open-market buy | Common Stock | $3.00M | +3.0M +171.64% | 4,747,794 | high |
| May 15, 2023 | Friedberg Albert Director | Grant Grant or award | Common Stock | $2.51M | +6.7M +34.41% | 26,216,904 | low |
| Nov 23, 2022 | Friedberg Albert Director | Grant Grant or award | Common Stock | $2.00M | +3.8M +32.63% | 15,359,011 | low |
| Jan 27, 2022 | Friedberg Albert Director | Buy Open-market buy | Common Stock | $2.00M | +1.8M +18.43% | 11,580,436 | high |
| Jan 27, 2022 | Friedberg Albert Director | Buy Open-market buy | Common Stock | $2.00M | +1.8M +105.36% | 3,511,894 | high |
| Jan 27, 2022 | Zauderer Maurice CEO | Buy Open-market buy | Common Stock | $2.00M | +1.8M +164.14% | 2,899,554 | high |
| Mar 31, 2023 | Friedberg Albert Director | Grant Grant or award | Common Stock | $1.70M | +4.1M +27.00% | 19,505,352 | low |
| Sep 18, 2024 | Friedberg Albert Director | Exercise Option exercise | Common Stock | $1.21M | +214K +27.45% | 994,910 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VCNX | common | 918640301 |